BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23811052)

  • 1. Vaccine potential of recombinant cathepsin B against Fasciola gigantica.
    Chantree P; Phatsara M; Meemon K; Chaichanasak P; Changklungmoa N; Kueakhai P; Lorsuwannarat N; Sangpairoj K; Songkoomkrong S; Wanichanon C; Itagaki T; Sobhon P
    Exp Parasitol; 2013 Sep; 135(1):102-9. PubMed ID: 23811052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L.
    Sansri V; Meemon K; Changklungmoa N; Kueakhai P; Chantree P; Chaichanasak P; Lorsuwannarat N; Itagaki T; Sobhon P
    Vaccine; 2015 Mar; 33(13):1596-601. PubMed ID: 25701317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice.
    Kueakhai P; Changklungmoa N; Riengrojpitak S; Chaichanasak P; Meemon K; Chaithirayanon K; Chantree P; Sansri V; Itagaki T; Sobhon P
    Vaccine; 2013 Nov; 31(47):5518-23. PubMed ID: 24075921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined recombinant cathepsin L1H and cathepsin B3 vaccine against Fasciola gigantica infection.
    Kueakhai P; Changklungmoa N; Cheukamud W; Osotprasit S; Chantree P; Preyavichyapugdee N; Sobhon P; Meemon K
    Parasitol Int; 2021 Aug; 83():102353. PubMed ID: 33872795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice.
    Kueakhai P; Changklungmoa N; Chaichanasak P; Jaikua W; Itagaki T; Sobhon P
    Acta Trop; 2015 Oct; 150():71-8. PubMed ID: 26116785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of recombinant 2-Cys peroxiredoxin protein as a vaccine for Fasciola gigantica infection.
    Sangpairoj K; Apisawetakan S; Changklungmoa N; Kueakhai P; Chaichanasak P; Sobhon P; Chaithirayanon K
    Exp Parasitol; 2018 Nov; 194():16-23. PubMed ID: 30240576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine potential of recombinant cathepsinL1G against Fasciola gigantica in mice.
    Changklungmoa N; Phoinok N; Yencham C; Sobhon P; Kueakhai P
    Vet Parasitol; 2016 Aug; 226():124-31. PubMed ID: 27514897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and vaccine potential of Fasciola gigantica saposin-like protein 1 (SAP-1).
    Kueakhai P; Changklungmoa N; Waseewiwat P; Thanasinpaiboon T; Cheukamud W; Chaichanasak P; Sobhon P
    Vet Parasitol; 2017 Jan; 233():115-122. PubMed ID: 28043381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and expression of cathepsin B2 in Fasciola gigantica.
    Chantree P; Wanichanon C; Phatsara M; Meemon K; Sobhon P
    Exp Parasitol; 2012 Oct; 132(2):249-56. PubMed ID: 22885402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic superoxide dismutase can provide protection against Fasciola gigantica.
    Jaikua W; Kueakhai P; Chaithirayanon K; Tanomrat R; Wongwairot S; Riengrojpitak S; Sobhon P; Changklungmoa N
    Acta Trop; 2016 Oct; 162():75-82. PubMed ID: 27338185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with recombinant leucine aminopeptidase showed protection against Fasciola gigantica in mice.
    Changklungmoa N; Kueakhai P; Riengrojpitak S; Chaithirayanon K; Chaichanasak P; Preyavichyapugdee N; Chantree P; Sansri V; Itagaki T; Sobhon P
    Parasitol Res; 2013 Oct; 112(10):3653-9. PubMed ID: 23917327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
    Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
    Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, expression and immunolocalization of cathepsin B3, a stage-specific antigen expressed by juvenile Fasciola gigantica.
    Sethadavit M; Meemon K; Jardim A; Spithill TW; Sobhon P
    Acta Trop; 2009 Nov; 112(2):164-73. PubMed ID: 19632187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of buffaloes with Fasciola gigantica recombinant fatty acid binding protein.
    Nambi PA; Yadav SC; Raina OK; Sriveny D; Saini M
    Parasitol Res; 2005 Sep; 97(2):129-35. PubMed ID: 15986249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning, characterization and functional analysis of a novel juvenile-specific cathepsin L of Fasciola gigantica.
    Sansri V; Changklungmoa N; Chaichanasak P; Sobhon P; Meemon K
    Acta Trop; 2013 Oct; 128(1):76-84. PubMed ID: 23820262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Fasciola gigantica infection using a monoclonal antibody-based sandwich ELISA for detection of circulating cathepsin B3 protease.
    Anuracpreeda P; Chawengkirtikul R; Tinikul Y; Poljaroen J; Chotwiwatthanakun C; Sobhon P
    Acta Trop; 2013 Jul; 127(1):38-45. PubMed ID: 23567552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.